BlackRock’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-959
| Closed | -$1.92K | – | 5722 |
|
|
2023
Q1 | $1.92K | Sell |
959
-2,319
| -71% | -$6.87K | ﹤0.01% | 5445 |
|
|
2022
Q4 | $12K | Sell |
3,278
-65
| -2% | -$276 | ﹤0.01% | 5441 |
|
|
2022
Q3 | $13K | Sell |
3,343
-77
| -2% | -$547 | ﹤0.01% | 5571 |
|
|
2022
Q2 | $21K | Sell |
3,420
-86,657
| -96% | -$809K | ﹤0.01% | 5547 |
|
|
2022
Q1 | $1.02M | Sell |
90,077
-2,896
| -3% | -$36.9K | ﹤0.01% | 4660 |
|
|
2021
Q4 | $1.47M | Buy |
92,973
+2,111
| +2% | +$44.7K | ﹤0.01% | 4518 |
|
|
2021
Q3 | $2.19M | Buy |
90,862
+2,469
| +3% | +$74.2K | ﹤0.01% | 4283 |
|
|
2021
Q2 | $3.08M | Sell |
88,393
-7,387
| -8% | -$294K | ﹤0.01% | 4088 |
|
|
2021
Q1 | $4.61M | Buy |
95,780
+2,074
| +2% | +$120K | ﹤0.01% | 3976 |
|
|
2020
Q4 | $4.54M | Buy |
93,706
+3,992
| +4% | +$150K | ﹤0.01% | 3754 |
|
|
2020
Q3 | $3.15M | Sell |
89,714
-3,754
| -4% | -$212K | ﹤0.01% | 3761 |
|
|
2020
Q2 | $6.42M | Buy |
93,468
+91,828
| +5,599% | +$3.66M | ﹤0.01% | 3424 |
|
|
2020
Q1 | $39K | Buy |
1,640
+114
| +7% | +$2.73K | ﹤0.01% | 4523 |
|
|
2019
Q4 | $24K | Buy |
1,526
+1,161
| +318% | +$15.4K | ﹤0.01% | 4635 |
|
|
2019
Q3 | $4K | Hold |
365
| – | – | ﹤0.01% | 4816 |
|
|
2019
Q2 | $3K | Sell |
365
-69,554
| -99% | -$708K | ﹤0.01% | 4884 |
|
|
2019
Q1 | $964K | Sell |
69,919
-3,151
| -4% | -$36.5K | ﹤0.01% | 3922 |
|
|
2018
Q4 | $596K | Sell |
73,070
-85,138
| -54% | -$1.49M | ﹤0.01% | 4038 |
|
|
2018
Q3 | $3.73M | Buy |
158,208
+2,391
| +2% | +$91K | ﹤0.01% | 3583 |
|
|
2018
Q2 | $7.74M | Buy |
155,817
+12,900
| +9% | +$639K | ﹤0.01% | 3351 |
|
|
2018
Q1 | $6.54M | Sell |
142,917
-9,719
| -6% | -$488K | ﹤0.01% | 3307 |
|
|
2017
Q4 | $6.98M | Sell |
152,636
-25,082
| -14% | -$1.33M | ﹤0.01% | 3313 |
|
|
2017
Q3 | $11M | Buy |
177,718
+9,447
| +6% | +$553K | ﹤0.01% | 3118 |
|
|
2017
Q2 | $10.7M | Buy |
168,271
+39,687
| +31% | +$2.2M | ﹤0.01% | 3130 |
|
|
2017
Q1 | $9.57M | Buy |
+128,584
| New | +$14.3M | ﹤0.01% | 3126 |
|
BlackRock's NH Position: Q2 2023 in Review
BlackRock sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 959 shares — an estimated $1.92K sold.
BlackRock first reported a position in NH in Q1 2017 and held it in 25 quarters. The position peaked at $11M in Q3 2017. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- BlackRock reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- BlackRock sold 959 NantHealth, Inc shares in Q2 2023, an estimated $1.92K.
- BlackRock first reported a position in NantHealth, Inc in Q1 2017 and held it in 25 quarters.
- BlackRock's NantHealth, Inc position peaked at $11M in Q3 2017.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.